WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
Related articles:
Related suggestion:
UN experts say South Sudan is close to securing a $13 billion oilParents of disabled children sue Indiana over Medicaid changes addressing $1 billion shortfallNelson Cruz hired by MLB as special adviser for baseball operationsShanna Moakler, 49, poses in a bikini on her exAn unusual autumn freeze grips parts of South America, giving Chile its coldest May in 74 yearsNFL schedule makers didn't seek out a Chiefs game close to a Taylor Swift concertPutin proposes reappointing Mishustin as Russian PM: mediaAI, digital technologies inject new impetus to cultural tourism boomFiorentina share spoils with Napoli in drawChicago Cubs second baseman Nico Hoerner misses 4th straight game with left hamstring issue
2.6538s , 6499.125 kb
Copyright © 2024 Powered by Vertex Pharma scientist talks about the long road to developing non ,World Wonders news portal